Non-operative Versus Operative Management of Perianal Abscess in Infants: A 10-year Retrospective Study at Two

J J Neville1, K Humpleby2, C Healy3

  • 1Department of Paediatric Surgery, Southampton Children's Hospital, University Hospitals Southampton NHS Foundation Trust, Southampton, UK; Department of Paediatric Surgery, Royal Alexandra Children's Hospital, Brighton, UK; University Surgery Unit, Faculty of Medicine, University of Southampton, Southampton, UK.

PubMed

Insights

Infant perianal abscess (PA) management: Operative treatment significantly reduces recurrence and further surgery compared to non-operative approaches. Fistula-in-ano rates remain similar regardless of initial PA treatment.

Area of Science:

  • Pediatric Surgery
  • Surgical Outcomes
  • Infant Health

Background:

  • Perianal abscess (PA) and fistula-in-ano (FIA) are common in infants.
  • Current PA management lacks robust evidence, relying on surgeon preference.
  • Treatment options include operative (incision and drainage) and non-operative (antibiotics, aspiration) methods.

Purpose of the Study:

  • To compare outcomes of non-operative versus operative management for infant perianal abscess (PA).
  • To evaluate recurrence rates, need for further surgery, and fistula-in-ano development.

Main Methods:

  • Retrospective review of 116 infants (≤12 months) with PA over 10 years (2012-2022).
  • Data collected from two UK pediatric surgery centers.
  • Analysis of clinical features, management strategies, and patient outcomes.

Main Results:

  • Operative management was associated with significantly lower PA recurrence rates (23% vs. 53%, p=0.001).
  • Infants managed operatively required less subsequent surgery (16% vs. 36%, p=0.026).
  • Rates of subsequent fistula-in-ano (FIA) did not differ significantly between groups (19% vs. 32%, p=0.129).

Conclusions:

  • Initial non-operative management of infant perianal abscess (PA) leads to higher recurrence and re-operation rates.
  • Operative intervention is independently associated with reduced PA recurrence risk.
  • Fistula-in-ano (FIA) development rates are comparable irrespective of initial PA treatment.
Abstract